NCT06721351Active, not recruiting
Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence
Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence -DRES-POCAI: AI - Clinical Intervention at San Ysidro Health
Source: ClinicalTrials.gov · Last updated 6 Nov 2025
Brief summary (registry, in English)
This research study is being conducted to improve eye care by using artificial intelligence (AI) to make diabetic eye screenings faster and more accessible. AI technology mimics human decision-making, enabling computers and systems to analyze medication information. Specifically for this screening, AI examines digital images of the eye and based on that information, may identify if a participant has diabetic retinopathy. It can assist doctors in making decisions about a participant's diagnosis, treatment or care plans to improve patient care. This is a collaboration between San Ysidro Health (SYHealth), University of California, San Diego (UC San Diego), and Eyenuk. The Kaiser Permanente Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) awarded SYHealth funds to demonstrate the value of AI technologies in diverse, real-world settings.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 548 (actual)
- First submitted
- 20 Nov 2024
- Start date
- 27 Jul 2024
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Centro De Salud La Comunidad De San Ysidro Inc DBA: San Ysidro Health
- Diseases
- Diabetic eye disease
- NCT number
- NCT06721351
What you commit to
- Study type: Interventional
- Participants enrolled: 548
- From 27 Jul 2024 to the primary completion date, 31 Dec 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- have a prior diagnosis of DR, macular edema, or retinal vascular occlusion;
Other illness
- have persistent visual Impairment in one or both eyes;
- history of ocular injections, laser treatment of the retina, or intraocular surgery (excluding cataract surgery);
- diagnosis of mental or degenerative disease that prevents self-consent for the study.
Other
- pregnant women; and
Who the study is looking for
- Capacity to provide informed consent. Individuals must have the capacity to understand the study information, risks, and benefits and voluntarily provide informed consent.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Established and active patient of SYHealth-CV and KC (having a medical appointment in the last 18 months).
- Person aged 22 and older.
- Established diagnosis of DM.
- Medical appointment(s) (in-person or telehealth) scheduled during the intervention period.
- Has not completed a dilated eye exam or retinal exam in the last 11months.
Age in the registry: 22 years to - · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| San Ysidro Health Chula Vista Coordinator of this site? Confirm its status | Chula Vista | United States | Unknown status |
| San Ysidro Health - Comprehensive Health Center - Ocean View Coordinator of this site? Confirm its status | San Diego | United States | Unknown status |
| San Ysidro Health King-Chavez Health Center Coordinator of this site? Confirm its status | San Diego | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.